Furthermore, functional single-nucleotide polymorphisms (SNPs) located in the promoter region of CCL2 and CXCL8, and thus regulating transcription of these chemokines, have been associated with clinical breast cancer outcome [9]–[11]. The gene discussed is CCL2; the disease is breast carcinoma.